Insider · CIK 0001251213

Bentsur RON

CIK 0001251213 Name as filed on the most recent filing

Filed as Bentsur RON (96)

155 transaction lines · from 96 filings · filed 2006-03-31 to 2026-07-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

155 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-08-03 S, Open-market sale Beyond Air, Inc.XAIR 23,489, disposed Open Form 4 filing 0001493152-20-014601
2020-07-31 S, Open-market sale Beyond Air, Inc.XAIR 17,970, disposed Open Form 4 filing 0001493152-20-014601
2020-07-30 S, Open-market sale Beyond Air, Inc.XAIR 21,404, disposed Open Form 4 filing 0001493152-20-014402
2020-07-29 S, Open-market sale Beyond Air, Inc.XAIR 2 lines 26,731, disposed Open Form 4 filing 0001493152-20-014402
2020-07-27 S, Open-market sale Beyond Air, Inc.XAIR 30,807, disposed Open Form 4 filing 0001493152-20-015397
2015-04-06 S, Open-market sale Keryx Biopharmaceuticals IncKERX 18,595, disposed Open Form 4 filing 0001209191-15-033263
2015-03-18 S, Open-market sale Stemline Therapeutics IncSTML 22,375, disposed Open Form 4 filing 0001104659-15-021407
2015-01-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 76,865, disposed Open Form 4 filing 0001209191-15-002623
2014-12-30 S, Open-market sale Keryx Biopharmaceuticals IncKERX 2,822,000, disposed Open Form 4 filing 0001209191-15-000384
2014-12-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,230,072, disposed Open Form 4 filing 0001209191-14-078282
2014-12-26 S, Open-market sale Keryx Biopharmaceuticals IncKERX 887,730, disposed Open Form 4 filing 0001209191-14-078282
2014-12-24 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,160,340, disposed Open Form 4 filing 0001209191-14-078282
2014-12-23 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,460,756, disposed Open Form 4 filing 0001209191-14-078282
2014-10-06 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,091,856, disposed Open Form 4 filing 0001209191-14-062373
2014-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 32,893, disposed Open Form 4 filing 0001209191-14-062373
2014-09-12 S, Open-market sale Keryx Biopharmaceuticals IncKERX 712,000, disposed Open Form 4 filing 0001209191-14-057795
2014-07-07 S, Open-market sale Keryx Biopharmaceuticals IncKERX 28,161, disposed Open Form 4 filing 0001209191-14-046589
2014-04-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 29,891, disposed Open Form 4 filing 0001209191-14-026236
2014-01-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 66,080, disposed Open Form 4 filing 0001181431-14-001476
2013-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 25,676, disposed Open Form 4 filing 0001181431-13-052945
2013-07-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 19,398, disposed Open Form 4 filing 0001181431-13-039326
2013-04-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 12,439, disposed Open Form 4 filing 0001144204-13-020684
2013-03-27 S, Open-market sale Keryx Biopharmaceuticals IncKERX 214,869, disposed Open Form 4 filing 0001144204-13-018769
2013-01-04 S, Open-market sale Keryx Biopharmaceuticals IncKERX 16,467, disposed Open Form 4 filing 0001144204-13-000858
2012-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 2,029, disposed Open Form 4 filing 0001144204-12-055033
2012-07-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,361, disposed Open Form 4 filing 0001144204-12-038524
2012-04-18 P, Open-market purchase Keryx Biopharmaceuticals IncKERX 2 lines 24,773, acquired Open Form 4 filing 0001144204-12-022617
2012-04-04 P, Open-market purchase Keryx Biopharmaceuticals IncKERX 98,525, acquired Open Form 4 filing 0001144204-12-020117
2012-01-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 8,676, disposed Open Form 4 filing 0001144204-12-000308
2011-08-10 P, Open-market purchase Keryx Biopharmaceuticals IncKERX 2 lines 22,905, acquired Open Form 4 filing 0001144204-11-045467
2011-03-24 S, Open-market sale Keryx Biopharmaceuticals IncKERX 137,621, disposed Open Form 4 filing 0001144204-11-017343
2010-12-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 250,500, disposed Open Form 4 filing 0001144204-10-065069
2010-12-02 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,038,078, disposed Open Form 4 filing 0001144204-10-065069
2010-03-24 S, Open-market sale Keryx Biopharmaceuticals IncKERX 91,713, disposed Open Form 4 filing 0001144204-10-015659
2009-06-23 P, Open-market purchase Keryx Biopharmaceuticals IncKERX 4,997, acquired Open Form 4 filing 0001144204-09-034093
2009-05-22 P, Open-market purchase Keryx Biopharmaceuticals IncKERX 5 lines 29,767, acquired Open Form 4 filing 0001144204-09-029245
2007-08-21 P, Open-market purchase XTL Biopharmaceuticals LtdXTLB 19,863, acquired Open Form 4 filing 0001144204-07-045600
2006-08-25 P, Open-market purchase XTL Biopharmaceuticals LtdXTLB 4,768, acquired Open Form 4 filing 0001144204-06-036007
2006-03-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 243,704, disposed Open Form 4 filing 0001144204-06-013308
2006-03-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 156,206, disposed Open Form 4 filing 0001144204-06-013308
2006-03-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 84,510, disposed Open Form 4 filing 0001144204-06-013308
2006-03-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 47,012, disposed Open Form 4 filing 0001144204-06-013308
2006-03-29 S, Open-market sale Keryx Biopharmaceuticals IncKERX 37,660, disposed Open Form 4 filing 0001144204-06-013308

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 91
  • Open-market sale 64
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BENTSUR RON, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001251213

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.